Miller Seline E.
SEC CIK 1769866 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | SVP Fin, Interim CFO, PAO | 0 | $3,022 | — | 3 | 2022-02-09 | 2023-08-31 |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-01 | 2023-08-31 | GYRE | GYRE THERAPEUTICS, INC. | Miller Seline E. | SVP Fin, Interim CFO, PAO | D - Sale to Iss | — | -6.50 | 0 | -100% | — | |
| 2022-08-10 | 2022-08-09 | GYRE | GYRE THERAPEUTICS, INC. | Miller Seline E. | SVP Fin, Interim CFO, PAO | P - Purchase | $0.47 | +3,250 | 6,500 | +100% | +$1,528 | |
| 2022-02-16 | 2022-02-09 | GYRE | GYRE THERAPEUTICS, INC. | Miller Seline E. | SVP Fin, Interim CFO, PAO | P - Purchase | $0.46 | +3,250 | 3,250 | New | +$1,495 |
Purchase Sale Sale after option exercise All abbreviations